Antony Cooper is a cell and molecular biologist with strong research interests into the causative mechanism(s) of Parkinson’s disease and approaches to ameliorate them. His work has extended into genomics and bioinformatics using transcriptomic data from patient brain regions affected in disease using RNA seq and RNA CapSeq, which was the catalyst for his lab developing bioinformatics and machine-learning models to discover differences within the brain transcriptome of Parkinson’s patients. This transcriptomic analysis extended to identify blood RNA signatures to act as peripheral biomarkers for Parkinson’s diagnosis and/or disease progression that are currently being tested. Recently he has been appointed research director of the Australian Parkinson’s Mission to integrate peripheral biomarkers and genomics into Parkinson’s clinical trials.